REVIEW article
Front. Cell Dev. Biol.
Sec. Cell Death and Survival
This article is part of the Research TopicFerroptosis: Intersections, Implications, and Innovations in Programmed Cell Death, Volume IIView all articles
The title: Ferroptosis at the Intersection of Osteoarthritis and Bone Metabolism: Mechanistic Links and Therapeutic Prospects
Provisionally accepted- 1Graduate School, Anhui University of Chinese Medicine, Hefei, China
- 2The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Osteoarthritis (OA) is a highly prevalent and debilitating degenerative joint disorder worldwide, characterized by complex pathogenesis and a lack of effective disease-modifying therapies. The traditional perspective has evolved from a simplistic "cartilage wear" model to a "whole-joint" pathology encompassing synovitis, aberrant subchondral bone remodeling, and chondrocyte death. In recent years, ferroptosis has emerged as a critical player in OA pathogenesis because of its unique regulatory mechanisms. Accumulating evidence indicates that ferroptosis contributes to OA progression through core processes, including intracellular iron overload, antioxidant system collapse, and excessive lipid peroxidation. These events not only directly trigger chondrocyte death and extracellular matrix degradation but also exacerbate bone metabolic imbalance through intricate signaling networks. Notably, the proposed "iron overload–inflammation–bone metabolism" vicious cycle underscores the central role of ferroptosis in linking cartilage degeneration to abnormal subchondral bone remodeling, providing a novel conceptual framework for understanding the "cartilage– bone" axis in OA. This review systematically outlines the molecular mechanisms of ferroptosis and its functional roles in OA chondrocytes and bone metabolism, emphasizing the pathological implications of this vicious cycle. We further discuss preclinical advances in targeting ferroptosis as a therapeutic strategy, analyze the challenges in clinical translation, and highlight future directions to inform the development of precise OA treatments.
Keywords: bone metabolism, Chondrocytes, ferroptosis, Inflammation, Osteoarthritis, Osteoblasts, Osteoclasts
Received: 10 Oct 2025; Accepted: 28 Nov 2025.
Copyright: © 2025 Xiao, Yan, Chen, Hong and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zhu Yan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
